Alerts
ctDNA Is Becoming the New Argument Over Chemotherapy
New GALAXY data suggest ctDNA status may identify which patients with colorectal liver metastases benefit from adjuvant chemotherapy after surgery. The promise is precision. The danger is moving faster than the evidence.
Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy
In Australia, Cancer Medicine Delays Cost More Than Time
Cancer Progress Still Depends on Your Postcode
A Boot-Camp Flu Outbreak Put Pentagon Vaccine Policy to the Test.
England Moved the Vaccine Clock. The Coverage Gap Stayed Put
Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.
MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.
Diphtheria Came Back. Remote Communities Are Carrying the Cost.
The Biomarker Test Cannot Wait Until Relapse
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.